Genpharmasec Ltd. - Research Center
531592 GENPHARMA Group (XT) BSE data
Results
Statement
More
Mar ' 23 |
Mar ' 22 |
Mar ' 21 |
Mar ' 20 |
Mar ' 19 |
Equity share capital
27.69 |
27.69 |
27.69 |
21.69 |
21.69 |
Share application money
Preference share capital
Reserves & surplus
-12.36 |
-12.32 |
-7.02 |
-4.15 |
-1.57 |
Secured loans
Unsecured loans
Total
18.41 |
15.37 |
20.66 |
19.03 |
21.61 |
Gross block
Less : revaluation reserve
Less : accumulated depreciation
Net block
Capital work-in-progress
Investments
Current assets, loans & advances
18.82 |
19.10 |
19.97 |
18.95 |
14.17 |
Less : current liabilities & provisions
Total net current assets
17.36 |
12.82 |
12.81 |
13.23 |
14.08 |
Miscellaneous expenses not written
Total
18.41 |
15.37 |
20.66 |
19.03 |
21.61 |
Book value of unquoted investments
Market value of quoted investments
Contingent liabilities
Number of equity sharesoutstanding (Lacs)
2768.60 |
2768.60 |
276.86 |
216.86 |
216.86 |